LAB Standard BioTools Inc.
LAB Standard BioTools Inc.
Healthcare · Medical Devices
Market read
POC $0.88 · VWAP $1.01 · -37.5% vs 12m avg buyer
Insiders quiet 0 buy / 0 sell · Form 4, 90d
Coverage
1 watchlist
LAB Price Structure
Loading timeframes…
Peers
Every watchlist LAB belongs to, members best 30-day change first — LAB highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@biotech-capital-cycle
Reported the quarter ending 2026-06-30: revenue $20M, diluted EPS -$0.07, net income -$27M (SEC filing). Across the print the stock moved -2.5% (close before → first close after).
full note →Against street estimates
How LAB's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. EPS only.
LAB research tape
9 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.